These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12141409)
1. Epsilon-aminocaproic acid and renal complications: case report and review of the literature. Manjunath G; Fozailoff A; Mitcheson D; Sarnak MJ Clin Nephrol; 2002 Jul; 58(1):63-7. PubMed ID: 12141409 [TBL] [Abstract][Full Text] [Related]
2. Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation. Nicolau-Raducu R; Ku TC; Ganier DR; Evans BM; Koveleskie J; Daly WJ; Fish B; Cohen AJ; Reichman TW; Bohorquez HE; Bruce DS; Carmody IC; Loss GE; Gitman M; Marshall T; Nossaman BD J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):917-23. PubMed ID: 27020101 [TBL] [Abstract][Full Text] [Related]
3. The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients. Stafford-Smith M; Phillips-Bute B; Reddan DN; Black J; Newman MF Anesth Analg; 2000 Nov; 91(5):1085-90. PubMed ID: 11049888 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant use of epsilon-aminocaproic acid (Amicar) in the endovascular treatment of cranial arteriovenous fistulae. Kallmes DF; Marx WF; Jensen ME; Cloft HJ; Do HM; Lanzino G; West K; Dion JE Neuroradiology; 2000 Apr; 42(4):302-8. PubMed ID: 10872177 [TBL] [Abstract][Full Text] [Related]
5. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety. Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855 [TBL] [Abstract][Full Text] [Related]
7. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584 [TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. Wassenaar T; Black J; Kahl B; Schwartz B; Longo W; Mosher D; Williams E Hematol Oncol; 2008 Dec; 26(4):241-6. PubMed ID: 18613223 [TBL] [Abstract][Full Text] [Related]
9. Obstruction of the renal pelvis due to an insoluble blood clot after epsilon-aminocaproic acid therapy: resolution with intraureteral streptokinase instillations. Wymenga LF; van der Boon WJ J Urol; 1998 Feb; 159(2):490-2. PubMed ID: 9649269 [TBL] [Abstract][Full Text] [Related]
10. Epsilon aminocaproic acid is associated with acute kidney injury after life-threatening hemorrhage in children. Kolodziej JH; Leeper CM; Leonard JC; Josephson CD; Zenati MS; Spinella PC Transfusion; 2023 May; 63 Suppl 3():S26-S34. PubMed ID: 37070413 [TBL] [Abstract][Full Text] [Related]
11. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364 [TBL] [Abstract][Full Text] [Related]
12. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report. Prandota J; Pankow-Prandota L; Kotecki L; Noga L Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663 [TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192 [TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. Burchiel KJ; Hoffman JM; Bakay RA Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999 [TBL] [Abstract][Full Text] [Related]
15. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid. Pitts TO; Spero JA; Bontempo FA; Greenberg A Am J Kidney Dis; 1986 Dec; 8(6):441-4. PubMed ID: 3812474 [TBL] [Abstract][Full Text] [Related]
16. Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series. Simon RP; Oromendia C; Sanso LM; Ramos LG; Rajwani K Pulm Pharmacol Ther; 2020 Feb; 60():101871. PubMed ID: 31783097 [TBL] [Abstract][Full Text] [Related]
17. Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract. Stefanini M; English HA; Taylor AE J Urol; 1990 Mar; 143(3):559-61. PubMed ID: 2304169 [TBL] [Abstract][Full Text] [Related]
18. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty. Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909 [TBL] [Abstract][Full Text] [Related]
19. Con: Antifibrinolytics Should Not Be Used Routinely in Low-Risk Cardiac Surgery. Harvey R; Salehi A J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):248-51. PubMed ID: 26613643 [No Abstract] [Full Text] [Related]
20. Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation. Geltzeiler J; Schwartz D Urology; 1984 Jul; 24(1):64-6. PubMed ID: 6740850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]